2048 Ventures
Sandra Pérez Baos, Ph.D., is a postdoctoral research scientist at NYU Grossman School of Medicine, specializing in immunology and T cell mRNA translation since September 2019. Notable achievements include developing therapeutic strategies for cancer and autoimmune conditions and managing various multidisciplinary research projects. Sandra has also served as an expert for BioExpert Network, evaluating biotech pitch decks for investment, and held leadership roles in Nucleate, where focus was on startup formation and academic innovation assessment. Previous experience includes research management at Fundación Jiménez Díaz Institute for Medical Research and contributions to NYU's technology commercialization efforts, alongside extensive academic credentials with a Ph.D. in Molecular Biosciences and multiple fellowships in relevant fields.
This person is not in any teams
2048 Ventures
1 followers
2048 Ventures is an early stage venture capital firm. They invest in exceptional first-time entrepreneurs who are building businesses differentiated through technology. They are based in NYC, and invest in founders from New York, Boston and Emerging Tech Cities.